Optima Medical Innovations Past Earnings Performance

Past criteria checks 0/6

Optima Medical Innovations has been growing earnings at an average annual rate of 1.5%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 38% per year.

Key information

1.5%

Earnings growth rate

43.1%

EPS growth rate

Pharmaceuticals Industry Growth	23.1%
Revenue growth rate	38.0%
Return on equity	-11.6%
Net Margin	-18.8%
Last Earnings Update	30 Sep 2021

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Optima Medical Innovations makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

CNSX:OMIC Revenue, expenses and earnings (USD Millions)
Date	Revenue	Earnings	G+A Expenses
30 Sep 21	2	0	0
30 Jun 21	2	0	0
31 Mar 21	5	-3	2
31 Dec 20	5	-4	3
30 Sep 20	7	-16	6
30 Jun 20	8	-18	8
31 Mar 20	6	-17	6
31 Dec 19	5	-18	7
30 Sep 19	4	-11	7
30 Jun 19	3	-10	6
31 Mar 19	1	-17	9
31 Dec 18	1	-16	8
30 Sep 18	1	-10	7
30 Jun 18	1	-10	6
31 Mar 18	0	-4	4
31 Dec 17	0	-6	6
31 Dec 16	0	-1	1

Quality Earnings: OMIC is currently unprofitable.

Growing Profit Margin: OMIC is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: OMIC is unprofitable, but has reduced losses over the past 5 years at a rate of 1.5% per year.

Accelerating Growth: Unable to compare OMIC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: OMIC is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).

Return on Equity

High ROE: OMIC has a negative Return on Equity (-11.58%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2022/08/06 14:32
End of Day Share Price	2022/05/09 00:00
Earnings	2021/09/30
Annual Earnings	2020/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Optima Medical Innovations Corp. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution